Who
Yousha Neman-Ebrahim
Chief Clinical Officer
Company insider
Files Form 4 as: Chief Clinical Officer, NeOnc Technologies Holdings.
In numbers
- Trades disclosed
- 5
- Buys
- 2
- Sells
- 0
- Bought
- $12K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Jun 2025
- Last trade
- 23 Apr 2026
- Last filed
- 24 Apr 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Apr 2026filed 24 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $2,440500 at $4.88 | filing |
| 23 Apr 2026filed 24 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $2,440500 at $4.88 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $7,3591,100 at $6.69 | filing |
| 5 Jun 2025filed 9 Jun 2025 | NTHI NeOnc Technologies Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —67,000 | filing |
| 5 Jun 2025filed 9 Jun 2025 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Code A | —133,000 | filing |
News
No headline names them, or the companies they trade most, lately.